These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 33155879)

  • 1. Effects of the Use of Curcumin on Ulcerative Colitis and Crohn's Disease: A Systematic Review.
    Goulart RA; Barbalho SM; Lima VM; Souza GA; Matias JN; Araújo AC; Rubira CJ; Buchaim RL; Buchaim DV; Carvalho ACA; Guiguer ÉL
    J Med Food; 2021 Jul; 24(7):675-685. PubMed ID: 33155879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcuminoids from
    Cunha Neto F; Marton LT; de Marqui SV; Lima TA; Barbalho SM
    Crit Rev Food Sci Nutr; 2019; 59(13):2136-2143. PubMed ID: 29565637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of 31 Randomized Controlled Trials.
    Zeng L; Yang T; Yang K; Yu G; Li J; Xiang W; Chen H
    Front Immunol; 2022; 13():896476. PubMed ID: 35979355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.
    Coelho MR; Romi MD; Ferreira DMTP; Zaltman C; Soares-Mota M
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
    Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
    World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease.
    Meng ZW; Chang B; Sang LX
    World J Gastroenterol; 2024 Jan; 30(3):280-282. PubMed ID: 38314128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Curcumin as Adjuvant Therapy to Induce or Maintain Remission in Ulcerative Colitis Patients: an Evidence-based Clinical Review.
    Simadibrata M; Halimkesuma CC; Suwita BM
    Acta Med Indones; 2017 Oct; 49(4):363-368. PubMed ID: 29348389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Ma C; Panaccione NR; Nguyen TM; Guizzetti L; Parker CE; Hussein IM; Vande Casteele N; Khanna R; Dulai PS; Singh S; Feagan BG; Jairath V
    J Crohns Colitis; 2019 Sep; 13(9):1201-1216. PubMed ID: 31111881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases?
    Mazieiro R; Frizon RR; Barbalho SM; Goulart RA
    J Med Food; 2018 Nov; 21(11):1077-1085. PubMed ID: 29957091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook.
    Karthikeyan A; Young KN; Moniruzzaman M; Beyene AM; Do K; Kalaiselvi S; Min T
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33918207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.
    Cholapranee A; Hazlewood GS; Kaplan GG; Peyrin-Biroulet L; Ananthakrishnan AN
    Aliment Pharmacol Ther; 2017 May; 45(10):1291-1302. PubMed ID: 28326566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations.
    Baliga MS; Joseph N; Venkataranganna MV; Saxena A; Ponemone V; Fayad R
    Food Funct; 2012 Nov; 3(11):1109-17. PubMed ID: 22833299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse.
    Carvalho ACA; Souza GA; Marqui SV; Guiguer ÉL; Araújo AC; Rubira CJ; Goulart RA; Flato UAP; Bueno PCDS; Buchaim RL; Barbalho SM
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin therapy for ulcerative colitis remission: systematic review and meta-analysis.
    Goulart RA; Barbalho SM; Rubira CJ; Araújo AC; Lima VM; Rogerio Leoni B; Guiguer EL
    Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1171-1179. PubMed ID: 32772752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of adjuvant curcumin therapy in ulcerative colitis: A systematic review and meta-analysis.
    Yin J; Wei L; Wang N; Li X; Miao M
    J Ethnopharmacol; 2022 May; 289():115041. PubMed ID: 35091013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.